Search results for: Value-Based Pricing
Filter search results
Deliberative Processes in Decisions about Health Care Technologies
1 June 2009
…by economic calculations, but also by social value judgments such as those relating to equity and fairness. Factors such as uncertainty around key values, operational feasibility and stakeholder interests also…
The Preventive Health Revolution: Insights from the 2024 Annual Lecture
15 October 2024
…from a paper he co-authored on the economic value of targeting aging: primarily, that if gains to life are spent in deteriorating health, the value of these extra years of…
New Journal Article: Directly Eliciting Personal Utility Functions
31 July 2018
…helping respondents to reflect and deliberate on their preferences, and results in a personal value set for each individual. It therefore has the potential for use in individual decision-making contexts….
A Note on the Relationship Between Age and Health-related Quality of Life Assessment
12 December 2018
…a comparison between the differences in TTO values (i.e. differences between values obtained from the oldest respondents and those obtained from younger age groups) and estimates of minimum clinically important…
Personalised Medicine: Is it an Oil-Rush or Oil-Spill?
3 February 2020, 12:00am
…acquired in an interpretable manner, is useful. However, it is also disruptive and has the potential to challenge many existing institutions, regulations and pricing patterns. Some empirical examples will be…
Workshop on HTA and Regulatory Review
13 May 2010
…need to make informed decisions on access and pricing/reimbursement ‘Mismatched outcomes’ were identified as a particular concern during the workshop. These occur when ‘a regulatory body grants an accelerated approval…
2010 Lecture: US Health Care Reform
27 May 2010
… may have Specific implications for prescription medicine consumption and pricing Join us in what promises to be a fascinating exploration of the implications of change in the American approach to…
Two Economists Join OHE
10 March 2011
…Currently, his other projects at OHE include exploring the interdependence of medical research funding from public and charitable sources, and the effects of the EU Transparency Directive on pricing decisions….
Incentives for R&D for New Antimicrobial Drugs
31 August 2011
…use of antimicrobials reduces their value as resistance develops with use, a phenomenon the authors term a ‘utilisation externality.’ This occurs as a result of both: (a) inappropriate prescribing, both…